Medicine and Dentistry
Liver Disease
100%
COVID-19
70%
Disease
63%
Liver Cirrhosis
55%
Nonalcoholic Fatty Liver
42%
Attitude
42%
Bleeding
42%
Graft Versus Host Reaction
42%
Systematic Review
42%
Fibrosis
42%
National Inpatient Sample
26%
Alcohol Liver Cirrhosis
25%
Fatty Liver
24%
Hepatocellular Carcinoma
23%
Symptomatic Treatment
22%
Pulmonary Hypertension
21%
Vaccine Hesitancy
21%
Liver Graft
21%
Acute Liver Failure
21%
Primary Immunodeficiency
21%
Diffuse Large B-Cell Lymphoma
21%
Mixed Infection
21%
Antiviral Therapy
21%
Hepatitis Delta Virus
21%
Booster Dose
21%
Gastrointestinal Bleeding
21%
Antivirus Agent
21%
COVID-19 Vaccine
21%
Plasma Transfusion
21%
Liver Dysfunction
21%
Mirabegron
21%
Hepatitis B Virus
21%
FibroScan
21%
Hepatitis B
21%
Chronic Hepatitis B
21%
Esophageal Varices
21%
Hepatitis C
21%
Varices
21%
Cohort Analysis
21%
End Stage Liver Disease
21%
Fresh Frozen Plasma
21%
Dialysis Catheter
21%
Atherosclerosis
21%
Chronic Graft Versus Host Disease
21%
Left Ventricular Assist Device
21%
Alcohol Liver Disease
21%
Meta-Analysis
21%
Retrospective Study
21%
Chronic Hepatitis
21%
Insulin Sensitivity
21%
Keyphrases
Liver Disease
98%
COVID-19
70%
United States
57%
Cirrhosis
55%
Liver
47%
Non-alcoholic Fatty Liver Disease (NAFLD)
42%
Alcoholic Cirrhosis
32%
Nonalcoholic Steatohepatitis
30%
Hepatology
28%
Histology
26%
Alcoholic Liver Disease
25%
Bleeding
25%
Hepatic Steatosis
24%
National Inpatient Sample Database
24%
Hepatocellular Carcinoma
23%
Abnormal Liver Tests
23%
Hospitalization
21%
XMEN Disease
21%
Hepatic Involvement
21%
Hepatitis D Virus Infection
21%
NIH Consensus Criteria
21%
CD8-positive T Cells
21%
Chronic Hepatitis D
21%
Downhill Varices
21%
Gastrointestinal Bleeding
21%
Mirabegron
21%
Fibroscan
21%
Provider Attitudes
21%
Provider Practices
21%
Acute Variceal Hemorrhage
21%
Direct-acting Antivirals
21%
Practice Patterns
21%
Direct-acting Antiviral Therapy
21%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
21%
Hepatic Graft-versus-host Disease
21%
COVID-19 Vaccine Hesitancy
21%
COVID-19 Vaccine Attitudes
21%
Longitudinal Effects
21%
Inpatient Outcomes
21%
Systematic Meta-analysis
21%
Graft-versus-host Disease (GvHD)
21%
B Hepatitis
21%
Diffuse Large B-cell Lymphoma (DLBCL)
21%
Disease Mechanisms
21%
Sickle Cell Disease
21%
Subclinical Atherosclerosis
21%
Patient Cohort
21%
Time to Publication
21%
Glycosylation
21%
Hepatitis C
21%